LeonaBio (LONA) EBITDA Yield: History & Chart

LeonaBio, Inc.(LONA)

Biotechnology · Bothell, WA

$5.72+0.13 (+2.42%)

Delayed quote: Oct 6, 2026, 1:48 PM EDT

About LeonaBio, Inc.

LeonaBio, Inc. operates as a biopharmaceutical firm engaged in clinical-stage development. Its core mission revolves around crafting small molecule therapies aimed at revitalizing neurological function and arresting the advancement of neurodegenerative conditions. The company's active development portfolio encompasses ATH-1105, an experimental therapy for amyotrophic lateral sclerosis (ALS) that is currently undergoing Phase 1 clinical assessment. Similarly, ATH-1020 is also in Phase 1 trials, targeting various neurodegenerative disorders. Furthermore, LeonaBio has an array of earlier-stage compounds in preclinical research. The company, which was originally established as Athira Pharma, Inc., rebranded itself as LeonaBio, Inc. in January 2026. Founded in 2011, its corporate headquarters are situated in Bothell, Washington.

Bothell, WA

19 employees

leonabio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Mark J. Litton

View full financials

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
LeonaBio, Inc. (LONA)	$22.54M	N/A	N/A	N/A	N/A
Rein Therapeutics Inc. (RNTX)vs ›	$22.88M	N/A	N/A	N/A	N/A
Aytu BioPharma, Inc. (AYTU)vs ›	$22.11M	N/A	24.06%	27.42%	27.42%
TherapeuticsMD, Inc. (TXMD)vs ›	$23.26M	N/A	217.80%	229.94%	229.94%
Modular Medical, Inc. (MODD)vs ›	$21.56M	N/A	N/A	N/A	N/A
Quantum BioPharma Ltd. (QNTM)vs ›	$21.40M	N/A	N/A	N/A	N/A
Kyntra Bio, Inc. (KYNB)vs ›	$23.92M	N/A	1.43%	1.43%	1.43%
ABVC BioPharma, Inc. (ABVC)vs ›	$24.13M	N/A	0.01%	0.01%	0.01%
NextCure, Inc. (NXTC)vs ›	$20.32M	N/A	N/A	N/A	N/A
Atossa Therapeutics, Inc. (ATOS)vs ›	$24.94M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EBITDA YIELD

TTM

LeonaBio, Inc. (LONA)

$22.54M

N/A

Rein Therapeutics Inc. (RNTX)vs ›

$22.88M

N/A

Aytu BioPharma, Inc. (AYTU)vs ›

$22.11M

N/A

24.06%

27.42%

TherapeuticsMD, Inc. (TXMD)vs ›

$23.26M

N/A

217.80%

229.94%

Modular Medical, Inc. (MODD)vs ›

$21.56M

N/A

Quantum BioPharma Ltd. (QNTM)vs ›

$21.40M

N/A

Kyntra Bio, Inc. (KYNB)vs ›

$23.92M

N/A

1.43%

ABVC BioPharma, Inc. (ABVC)vs ›

$24.13M

N/A

0.01%

NextCure, Inc. (NXTC)vs ›

$20.32M

N/A

Atossa Therapeutics, Inc. (ATOS)vs ›

$24.94M

N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

EBITDA Yield: N/A

LONA EBITDA Yield Metrics

LONA Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics